About Immunoglobulin-mediated membranoproliferative glomerulonephritis
Immunoglobulin-mediated membranoproliferative glomerulonephritis is a rare disease catalogued by Orphanet (ORPHA:329903). It is associated with the CFH, DGKE genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Immunoglobulin-mediated membranoproliferative glomerulonephritis trials.
Search ClinicalTrials.gov for "Immunoglobulin-mediated membranoproliferative glomerulonephritis" or filter by Orphanet code ORPHA:329903 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Immunoglobulin-mediated membranoproliferative glomerulonephritis trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Immunoglobulin-mediated membranoproliferative glomerulonephritis. Updated daily.